Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02040545 · ClinicalTrials.gov registry record
Salivary Diagnostic Testing for IVF
A clinical trial of Infertility, sponsored by Boston IVF.
- Completed
- Registry status
- 335
- Enrollment target
- 8
- Study locations
NCT02040545: Completed study of Infertility, sponsored by Boston IVF.
NCT02040545 is a study of Infertility that has completed, run by Boston IVF. The registered enrollment target is 335 participants, below the 7,585-participant average among 74 other Infertility trials with a reported enrollment target (96% lower). The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02040545, a study of Infertility, has completed, sponsored by Boston IVF.
- COMPLETED
- Registry status
- 335 participants
- Enrollment target
- 8
- Study locations
Study Summary
This study aims to determine the performance of a salivary hormone competitive immunoassay for monitoring patients during treatment for infertility.
Primary Outcome
The potential applicability and reliability of salivary steroid monitoring during infertility treatment will be measured as a progression during a patient's IVF stimulation cycle. Concurrent saliva and blood draw measurements of Estradiol and Progesterone will be taken between 3-5 times during a 2-week monitoring period. Equivalence will be determined by the matched progression of Estradiol and progesterone levels (pg/ml) in the same patient at the concurrent times. Saliva Estradiol and Progeste
Conditions Studied
Study Locations (8)
Massachusetts
- Boston IVF - Quincy
- Boston IVF - Waltham
California
- HRC Fertility - Pasadena
Georgia
- Reproductive Biology Associates - Atlanta
Illinois
- Fertility Center of Illinois - Chicago
Maine
- Boston IVF - South Portland
Maryland
- Shady Grove Fertility Reproductive Science Center - Rockville
New York
- Reproductive Medicine Associates of New York, LLP - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 335 participants |
| Start Date | 2010-05-21 |
| Est. Completion | 2017-04-04 |
What the finished NCT02040545 record still lists
NCT02040545 is an observational study that tracks outcomes without assigning an intervention. The registered 335 participants enrollment target is mid-sized for trials with a published cap, below the 7,585-participant average among 74 other Infertility trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 0 interventions.
NCT02040545 lists 8 locations in 7 states (Massachusetts, California, Georgia).
Frequently Asked Questions
What is clinical trial NCT02040545 about?
NCT02040545 is a clinical study titled "Salivary Diagnostic Testing for IVF". This study aims to determine the performance of a salivary hormone competitive immunoassay for monitoring patients during treatment for infertility.
What is the current status of trial NCT02040545?
This trial is currently completed. The enrollment target is 335 participants. The study started on 2010-05-21. Estimated completion is 2017-04-04.
What conditions does trial NCT02040545 study?
This clinical trial studies the following conditions: Infertility.
Who is sponsoring clinical trial NCT02040545?
This trial is sponsored by Boston IVF, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02040545 being conducted?
This trial has 8 study locations across California, Georgia, Illinois, Maine, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02040545's enrollment target sits among peer trials
335 31st of 74 higher than 44 of 74 other Infertility trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
-
Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
RECRUITING · Phase 1
-
Non-Euploid Embryo Transfer (NEET) Registry
RECRUITING
-
Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield
RECRUITING · NA
-
Apple Women's Health Study
RECRUITING
-
Discarded Materials Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04134754 · 335 participants · NA
Carbon Dioxide (CO2) Chemosensitivity and SUDEP
- NCT05554406 · 335 participants · Phase 2
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
- NCT06183437 · 335 participants · Phase 4
The STOP-MED CTRCD Trial
- NCT06885177 · 335 participants · NA
TECTONIC CAD IVL IDE Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI